CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|
| Class A ordinary shares | |||
| ADS ratio | 650 | 650 | 650 |
| Cost of revenue | |||
| Share-based compensation expense | $ 8,160 | $ 20,456 | $ 21,434 |
| General and administrative expenses | |||
| Share-based compensation expense | 5,532 | 53,290 | 512,837 |
| Research and development expenses | |||
| Share-based compensation expense | 24,033 | 60,297 | 180,355 |
| Sales and marketing expenses | |||
| Share-based compensation expense | $ 0 | $ 517 | $ (10,061) |